Diagnostic value of urine cyclic RNA-0071196 for bladder urothelial carcinoma. 2024

Yang Yang, and Jun Li, and Weixiang Yao, and Ge Zou, and Xuying Ye, and Qishan Mo
Department of Urology, Panyu District Central Hospital, No.8 Fuyu East Road, Guangzhou, 510000, China.

OBJECTIVE To investigate the diagnostic value of urine cyclic RNA-0071196 (circRNA-0071196) in the patients with bladder urothelial carcinoma (BUC). METHODS The expression of circRNA-0071196 was detected in the urine samples using qRT-PCR from 40 BUC patients and 30 non-UBC patients at our department from December 2018 to September 2021. The expression difference of circRNA-0071196 was compared between the two groups, and the relationship between the expression of circRNA-0071196 in the urine of UBC patients and the clinical pathological characteristics was analyzed. RESULTS (1) The expression of circRNA-0071196 in the urine of BUC group was significantly higher than that in the non-BUC group (P < 0.05). (2) The expression of circRNA-0071196 in the urine of BUC group was not related to age, sex, or lymph node metastasis (P > 0.05). (3) The expression of circRNA-0071196 in the urine of BUC group was related to tumor T stage, tumor grade and muscle invasion. (4) The urine circRNA-0071196 expression effectively distinguished BUC patients from non-BUC patients. CONCLUSIONS The elevated expression of urine circRNA-0071196 in BUC patients indicates that circRNA-0071196 has promising potential as a non-invasive urinary biomarker for detecting BUC.

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001743 Urinary Bladder A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION. Bladder,Bladder Detrusor Muscle,Detrusor Urinae,Bladder Detrusor Muscles,Bladder, Urinary,Detrusor Muscle, Bladder,Detrusor Muscles, Bladder
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000079962 RNA, Circular RNA molecules in which the 3' and 5' ends are covalently joined to form a closed continuous loop. They are resistant to digestion by EXORIBONUCLEASES. Circular Intronic RNA,Circular RNA,Circular RNAs,Closed Circular RNA,ciRNA,circRNA,circRNAs,Circular RNA, Closed,Intronic RNA, Circular,RNA, Circular Intronic,RNA, Closed Circular,RNAs, Circular
D012313 RNA A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) RNA, Non-Polyadenylated,Ribonucleic Acid,Gene Products, RNA,Non-Polyadenylated RNA,Acid, Ribonucleic,Non Polyadenylated RNA,RNA Gene Products,RNA, Non Polyadenylated

Related Publications

Yang Yang, and Jun Li, and Weixiang Yao, and Ge Zou, and Xuying Ye, and Qishan Mo
March 1974, Urology,
Yang Yang, and Jun Li, and Weixiang Yao, and Ge Zou, and Xuying Ye, and Qishan Mo
July 2021, Cancer cytopathology,
Yang Yang, and Jun Li, and Weixiang Yao, and Ge Zou, and Xuying Ye, and Qishan Mo
January 2006, Acta cytologica,
Yang Yang, and Jun Li, and Weixiang Yao, and Ge Zou, and Xuying Ye, and Qishan Mo
November 2002, European urology,
Yang Yang, and Jun Li, and Weixiang Yao, and Ge Zou, and Xuying Ye, and Qishan Mo
June 2021, Translational andrology and urology,
Yang Yang, and Jun Li, and Weixiang Yao, and Ge Zou, and Xuying Ye, and Qishan Mo
February 2024, Cancers,
Yang Yang, and Jun Li, and Weixiang Yao, and Ge Zou, and Xuying Ye, and Qishan Mo
January 2022, Journal of immunology research,
Yang Yang, and Jun Li, and Weixiang Yao, and Ge Zou, and Xuying Ye, and Qishan Mo
September 2004, Clinical biochemistry,
Yang Yang, and Jun Li, and Weixiang Yao, and Ge Zou, and Xuying Ye, and Qishan Mo
June 2009, Der Urologe. Ausg. A,
Yang Yang, and Jun Li, and Weixiang Yao, and Ge Zou, and Xuying Ye, and Qishan Mo
May 2010, Clinical cancer research : an official journal of the American Association for Cancer Research,
Copied contents to your clipboard!